Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02139046 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout
A Phase 3 study, sponsored by Takeda.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,790
- Enrollment target
NCT02139046: Completed Phase 3 study, sponsored by Takeda.
NCT02139046 is a Phase 3 study that has completed, run by Takeda. The registered enrollment target is 1,790 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (132% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02139046, a Phase 3 study, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,790 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy and safety of febuxostat 40 mg extended release (XR) and 80 mg XR in comparison with febuxostat 40 mg immediate release (IR) and 80 mg IR, respectively, in participants with gout.
Interventions
- DRUG Colchicine
- DRUG Naproxen
- DRUG Febuxostat placebo
- DRUG Febuxostat IR
- DRUG Febuxostat XR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,790 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-11 |
| Phase | Phase 3 |
What the finished NCT02139046 record still lists
NCT02139046 is an interventional study that assigns participants to a tested intervention. Its 1,790 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (132% higher).
The record links to 0 conditions, and to 5 interventions - of which Colchicine is the first listed.
NCT02139046 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02139046 about?
NCT02139046 is a clinical study titled "Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout". The purpose of this study is to evaluate the efficacy and safety of febuxostat 40 mg extended release (XR) and 80 mg XR in comparison with febuxostat 40 mg immediate release (IR) and 80 mg IR, respectively, in participants with gout.
What is the current status of trial NCT02139046?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,790 participants. The study started on 2014-04. Estimated completion is 2015-11.
What interventions are being tested in trial NCT02139046?
The interventions under investigation include: Colchicine (DRUG), Naproxen (DRUG), Febuxostat placebo (DRUG), Febuxostat IR (DRUG), Febuxostat XR (DRUG).
Who is sponsoring clinical trial NCT02139046?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02139046's enrollment target sits among peer trials
1,790 125th of 2000 higher than 1,876 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05770570 · 1,785 participants · Phase 2
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- NCT04475640 · 1,800 participants · NA
Cancer Genetic Testing in Ethnic Populations
- NCT04980794 · 1,800 participants · NA
The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia